Document is current

Any future updates will be listed below

Correction: Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer

Crossref DOI link: https://doi.org/10.1038/srep24893

Published Online: 2016-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark